EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 163 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2023. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,786,000 | -24.4% | 57,525 | 0.0% | 0.05% | -12.1% |
| Q1 2022 | $2,362,000 | -5.6% | 57,525 | 0.0% | 0.06% | 0.0% |
| Q4 2021 | $2,501,000 | -13.2% | 57,525 | 0.0% | 0.06% | -17.1% |
| Q3 2021 | $2,880,000 | -18.3% | 57,525 | +2.9% | 0.07% | -13.6% |
| Q2 2021 | $3,523,000 | -32.2% | 55,925 | 0.0% | 0.08% | -34.7% |
| Q1 2021 | $5,196,000 | -1.1% | 55,925 | -4.6% | 0.12% | -4.6% |
| Q4 2020 | $5,253,000 | -19.5% | 58,625 | -7.1% | 0.13% | -27.4% |
| Q3 2020 | $6,523,000 | +18.5% | 63,125 | -9.3% | 0.18% | +27.0% |
| Q2 2020 | $5,506,000 | +35.3% | 69,625 | -1.0% | 0.14% | +17.5% |
| Q1 2020 | $4,069,000 | +4.7% | 70,325 | -2.4% | 0.12% | +48.1% |
| Q4 2019 | $3,887,000 | -45.5% | 72,045 | -47.2% | 0.08% | -43.8% |
| Q3 2019 | $7,128,000 | +22.8% | 136,344 | +13.5% | 0.14% | +30.9% |
| Q2 2019 | $5,803,000 | -0.5% | 120,110 | +4.1% | 0.11% | +0.9% |
| Q1 2019 | $5,832,000 | – | 115,434 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Laurus Investment Counsel Inc. | 119,994 | $12,399,000 | 6.09% |
| Hillcrest Asset Management LLC | 161,826 | $16,721,000 | 2.96% |
| SNYDER CAPITAL MANAGEMENT L P | 664,662 | $68,680,000 | 2.94% |
| Copper Rock Capital Partners, LLC | 83,374 | $8,615,000 | 2.91% |
| RICE HALL JAMES & ASSOCIATES, LLC | 623,132 | $64,388,000 | 2.60% |
| Tygh Capital Management, Inc. | 130,526 | $13,487,000 | 2.56% |
| PALISADE CAPITAL MANAGEMENT, LP | 428,875 | $44,316,000 | 1.31% |
| BECK CAPITAL MANAGEMENT, LLC | 22,067 | $2,280,000 | 1.29% |
| EARNEST PARTNERS LLC | 1,394,794 | $144,124,000 | 1.24% |
| DC Investments Management, LLC | 10,945 | $1,131,000 | 1.24% |